ADA 2026 Oral Cancer Detection Guidelines: Clinical Exam Prioritized Over Vital Staining

The ADA's updated 2026 living guideline for oral cancer detection recommends comprehensive clinical examination as the primary screening method for oral squamous cell carcinoma and potentially malignant disorders. It advises against using vital staining adjuncts (e.g., toluidine blue) to determine the need for biopsy. This applies to general dental practice and oral medicine, emphasizing early detection through visual and tactile exam.